Schaeffer’s Market Recap Daily Newsletter
Stocks Lock in Weekly Wins, Nasdaq Captures More Highs
Excitement surrounding Gilead Science's (GILD) COVID-19 treat sent stocks surging
Is it time to buy or sell options?
Analyst Can't Look Past Alarming BYND Headwinds
Citi initiated coverage with a "sell" rating and a $123 price target cut
Schaeffer’s 5 Minute Market Rundown Weekly Newsletter
Tech, Drug Stocks Lift Wall Street Spirits
The Nasdaq Composite (IXIC) surged to multiple record highs this week
Trading precious metals ETFs
Call Traders Blast Middling Mining Stock
A short squeeze could give Cleveland-Cliffs stock more momentum, too
Schaeffer’s Midday Market Check Daily Newsletter
Dow, S&P 500 Pivot Higher on Potential COVID-19 Treatment
Gilead Sciences announced possible COVID-19 treatment efficacy
Bull market and Bear market strategies
Put Volume Runs Rampant on SABR
The travel-adjacent stock is struggling this year
Spotify Technology SPOT stock news and analysis
SPOT Eyes Record Highs Despite App Outages
Several popular iOS apps were experiencing outages this morning
Stock market bull, bull statue, black and white bullish traders
Pizza Stock Hot After Overdue Bull Notes
Domino's Pizza (DPZ) earned price target hikes from MKM Partners and Oppenheimer this morning
Market uncertainty along with COVID-19 resurgence
Analyst Turns Bullish on Foot Locker Stock
Susquehanna upgraded the retailer to "positive" from "neutral"
Schaeffer’s Opening View Daily Newsletter
Stock Futures Pare Losses Amid New Vaccine Data
2 FAANG stocks have received bull notes this morning
The Biggest New Tech Breakthrough Is Here
This big tech trend could make you a fortune over the next few years
Schaeffer’s Market Recap Daily Newsletter
Nasdaq Gains on Tech Recovery; Vaccine News Swirls
Moderna's (MRNA) vaccine candidate will likely enter phase 3 trials by the end of the month

A Schaeffer's 39th Anniversary Exclusive!

8 Top Stock Picks for 2020

Access your FREE insider report before it's too late!